Publication date: Nov 07, 2019
Dr. Bruce Johnson, Chief Clinical Research Officer from the Dana Farber Cancer Institute, joins us to discuss how recent advances in treating rare cancers can help drive the understanding and expansion of precision medicine.
- Understanding Precision Medicine And AI Within The Life Cycle Of Technology Revolutions
- Clinical Computational Oncology for Precision Cancer Medicine
- Can Precision Medicine Be a Win-Win for All Stakeholders?
- Dr. Erica Stringer-Reasor shares her expertise on precision medicine advancements in breast cancer
- Super Session 4 NLSDays 2019 – Cancer Precision Medicine
- Building the Team to Decode Biology with Tina Larson | Talking Precision Medicine #16
- Keynote: The Algorithm for Precision Medicine
- Stanford Medicine Big Data Precision Health 2018
- Genomics & Precision Medicine – Prof. Kathryn North